Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene

REFERENCES

• Breidert, T., F. Spitzenberger, D. Gründemann, and E. Schömig. 1998. Catecholamine transport by the organic cation transporter type 1 (OCT1). Br. J. Pharmacol. 125:218–224.
   PubMed Web of Science ®Google Scholar
• Busch, A. E., S. Quester, J. C. Ulzheimer, S. Waldegger, V. Gorboulev, P. Arndt, F. Lang, and H. Koepsell. 1996. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J. Biol. Chem. 271:32599–32604.
   PubMed Web of Science ®Google Scholar
• Degrado, T. R., M. R. Zalutsky, and G. Vaidyanathan. 1995. Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart. Nucl. Med. Biol. 22:1–12.
   PubMedGoogle Scholar
• Dresser, M. J., L. Zhang, and K. M. Giacomini. 1999. Molecular and functional characteristics of cloned human organic cation transporters. Pharm. Biotechnol. 12:441–469.
   PubMedGoogle Scholar
• Glowniak, J. V., J. E. Kilty, S. G. Amara, B. J. Hoffman, and F. E. Turner. 1993. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J. Nucl. Med. 34:1140–1146.
   PubMed Web of Science ®Google Scholar
• Gorboulev, V., J. C. Ulzheimer, A. Akhoundova, I. Ulzheimer-Teuber, U. Karbach, S. Quester, C. Baumann, F. Lang, A. E. Busch, and H. Koepsell. 1997. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 16:871–881.
   PubMed Web of Science ®Google Scholar
• Gründemann, D., V. Gorboulev, S. Gambaryan, M. Veyhl, and H. Koepsell. 1994. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549–552.
   PubMed Web of Science ®Google Scholar
• Gründemann, D., S. Köster, N. Kiefer, T. Breidert, M. Engelhardt, F. Spitzenberger, N. Obermüller, and E. Schömig. 1998. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J. Biol. Chem. 273:30915–30920.
   PubMed Web of Science ®Google Scholar
• Irwin, I., L. E. DeLanney, D. Di Monte, and J. W. Langston. 1989. The biodisposition of MPP+ in mouse brain. Neurosci. Lett. 101:83–88.
   PubMed Web of Science ®Google Scholar
• Jaques, S., M. C. Tobes, J. C. Sisson, J. A. Baker, and D. M. Wieland. 1984. Comparison of the sodium dependency of uptake of meta-iodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol. Pharmacol. 26:539–546.
   PubMedGoogle Scholar
• Jonker, J. W., E. Wagenaar, L. van Deemter, R. Gottschlich, H. M. Bender, J. Dasenbrock, and A. H. Schinkel. 1999. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgesic drug. Br. J. Pharmacol. 127:43–50.
   PubMed Web of Science ®Google Scholar
• Karbach, U., J. Kricke, F. Meyer-Wentrup, V. Gorboulev, C. Volk, D. Loffing-Cueni, B. Kaissling, S. Bachmann, and H. Koepsell. 2000. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am. J. Physiol. Renal Physiol. 279:F679–F687.
   PubMed Web of Science ®Google Scholar
• Koepsell, H.. 1998. Organic cation transporters in intestine, kidney, liver, and brain. Annu. Rev. Physiol. 60:243–266.
   PubMed Web of Science ®Google Scholar
• Martel, F., T. Vetter, H. Russ, D. Gründemann, I. Azevedo, H. Koepsell, and E. Schömig. 1996. Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn Schmiedebergs Arch. Pharmacol. 354:320–326.
   PubMed Web of Science ®Google Scholar
• Mayer, U., E. Wagenaar, J. H. Beijnen, J. W. Smit, D. K. F. Meijer, J. van Asperen, P. Borst, and A. H. Schinkel. 1996. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdrla P-glycoprotein. Br. J. Pharmacol. 119:1038–1044.
   PubMed Web of Science ®Google Scholar
• Meyer-Wentrup, F., U. Karbach, V. Gorboulev, P. Arndt, and H. Koepsell. 1998. Membrane localization of the electrogenic cation transporter rOCT1 in rat liver. Biochem. Biophys. Res. Commun. 248:673–678.
   PubMed Web of Science ®Google Scholar
• Mitchell, S. C., J. R. Idle, and R. L. Smith. 1982. The metabolism of [14C]cimetidine in man. Xenobiotica 12:283–292.
   PubMed Web of Science ®Google Scholar
• Nagel, G., C. Volk, T. Friedrich, J. C. Ulzheimer, E. Bamberg, and H. Koepsell. 1997. A reevaluation of substrate specificity of the rat cation transporter rOCT1. J. Biol. Chem. 272:31953–31956.
   PubMed Web of Science ®Google Scholar
• Nelson, J. A., J. F. Kuttesch, and B. H. Herbert. 1983. Renal secretion of nucleosides and their analogs in mice. Biochem. Pharmacol. 32:2323–2327.
   PubMedGoogle Scholar
• Ogihara, H., H. Saito, B. Shin, T. Terada, S. Takenoshita, Y. Nagamachi, K. Inui, and K. Takata. 1996. Immuno-localization of H+/peptide cotransporter in rat digestive tract. Biochem. Biophys. Res. Commun. 220:848–852.
   PubMedGoogle Scholar
• Okuda, M., H. Saito, Y. Urakami, M. Takano, and K. Inui. 1996. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem. Biophys. Res. Commun. 224:500–507.
   PubMed Web of Science ®Google Scholar
• Schinkel, A. H., J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. Te Riele, A. J. M. Berns, and P. Borst. 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491–502.
   PubMed Web of Science ®Google Scholar
• Schweifer, N., and D. P. Barlow. 1996. The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters. Mamm. Genome 7:735–740.
   PubMed Web of Science ®Google Scholar
• Sinclair, C. J., K. D. Chi, V. Subramanian, K. L. Ward, and R. M. Green. 2000. Functional expression of a high affinity mammalian hepatic choline/organic cation transporter. J. Lipid Res. 41:1841–1848.
   PubMedGoogle Scholar
• Smit, J. J. M., A. H. Schinkel, R. P. J. Oude Elferink, A. K. Groen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, R. Ottenhof, N. M. T. van der Lugt, M. A. van Roon, M. A. van der Valk, G. J. A. Offerhaus, A. J. M. Berns, and P. Borst. 1993. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451–462.
   PubMed Web of Science ®Google Scholar
• Tamai, I., H. Yabuuchi, J. Nezu, Y. Sai, A. Oku, M. Shimane, and A. Tsuji. 1997. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419:107–111.
   PubMed Web of Science ®Google Scholar
• Taylor, P.. 1992. Agents acting at the neuromuscular junction and autonomic ganglia. The pharmacological basis of therapeutics.. A. Goodman Gilman, T. W. Rall, A. S. Nies, and P. Taylor. 166–185. McGraw-Hill, New York, N.Y
   Google Scholar
• Trocone, L., and V. Rufini. 1997. 131I-MIBG therapy of neural crest tumours. Anticancer Res. 17:1823–1831 (Review.)
   PubMedGoogle Scholar
• Urakami, Y., M. Okuda, S. Masuda, H. Saito, and K. Inui. 1998. Functional characteristics and membrane loacalization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J. Pharmacol. Exp. Ther. 287:800–805.
   PubMed Web of Science ®Google Scholar
• Van Dyke, R. W., E. D. Faber, and D. K. F. Meijer. 1992. Sequestration of organic cations by acidified hepatic endocytic vesicles and implications for biliary excretion. J. Pharmacol. Exp. Ther. 261:1–11.
   PubMed Web of Science ®Google Scholar
• Wafelman, A. R., Y. L. Nortier, H. Rosing, H. J. Maessen, B. G. Taal, C. A. Hoefnagel, R. A. Maes, and J. H. Beijnen. 1995. Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance. Nucl. Med. Commun. 16:767–772.
   PubMedGoogle Scholar
• Wieland, D. M., J. L. Wu, L. E. Brown, T. J. Mangner, D. P. Swanson, and W. H. Beierwaltes. 1980. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]-iodobenzylguanidine. J. Nucl. Med. 21:349–353.
   PubMed Web of Science ®Google Scholar
• Wu, X., R. Kekuda, W. Huang, Y. Fei, F. H. Leibach, J. Chen, S. J. Conway, and V. Ganapathy. 1998. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273:32776–32786.
   PubMed Web of Science ®Google Scholar
• Wu, X., P. D. Prasad, F. H. Leibach, and V. Ganapathy. 1998. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem. Biophys. Res. Commun. 246:589–595.
   PubMed Web of Science ®Google Scholar
• Zhang, L., M. E. Schaner, and K. M. Giacomini. 1998. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa) J. Pharmacol. Exp. Ther. 286:354–361.
   PubMed Web of Science ®Google Scholar